CN Stock MarketDetailed Quotes

001367 Zhejiang Haisen Pharmaceutical

Watchlist

28.34
-1.29-4.35%

Market Closed Nov 15 15:00 CST

2.91BMarket Cap24.31P/E (TTM)

Zhejiang Haisen Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

Assets

Current assets

Money funds

-21.90%723.69M

-22.86%700.71M

293.68%951.78M

281.79%943.75M

--926.65M

306.07%908.36M

--241.76M

20.43%247.19M

41.69%223.7M

46.71%205.26M

Transactional financial assets

--250M

----

--740.3K

Notes receivable and accounts receivable

-5.47%41.18M

-16.48%49.58M

9.00%59.05M

24.72%54.32M

--43.56M

24.68%59.37M

--54.17M

91.10%43.55M

2.51%47.61M

-18.39%22.79M

-Notes receivable

--5.49M

--6.27M

--6.28M

--2.58M

----

-Accounts receivable

-18.07%35.69M

-27.04%43.31M

-2.59%52.77M

18.78%51.73M

--43.56M

24.68%59.37M

--54.17M

91.10%43.55M

2.51%47.61M

-18.39%22.79M

Other receivables (including interest and dividends)

65.97%253.75K

144.81%188.04K

-40.08%119.16K

69.76%72.37K

--152.89K

27.99%76.81K

--198.88K

49.10%42.63K

-71.38%60.01K

-90.39%28.59K

-Other receivable

----

144.81%188.04K

----

27.99%76.81K

----

49.10%42.63K

--60.01K

-90.39%28.59K

Advance payment

8.70%4.84M

14.17%3.01M

-61.34%2.42M

-15.05%2.25M

--4.45M

56.70%2.64M

--6.26M

148.42%2.65M

-7.80%1.68M

19.84%1.07M

Inventories

-10.55%141.42M

7.30%150.15M

-0.44%130.31M

11.68%159.31M

--158.1M

10.14%139.94M

--130.89M

35.93%142.65M

39.08%127.06M

21.77%104.94M

Receivable financing

80.34%21.98M

1.24%23.43M

51.40%30.48M

-8.90%3.41M

--12.19M

21.18%23.14M

--20.13M

-82.83%3.75M

218.66%19.1M

86.54%21.82M

Other current assets

0.87%15.74M

38.34%14.01M

69.79%11.01M

133.79%14.87M

--15.61M

148.18%10.13M

--6.48M

54.99%6.36M

316.51%4.08M

8,094.62%4.1M

Total current assets

3.31%1.2B

4.15%1.19B

157.70%1.19B

164.01%1.18B

--1.16B

170.18%1.14B

--459.89M

23.68%446.19M

38.92%423.29M

35.14%360.75M

Non Current assets

Investment real estate

-7.16%3.93M

-7.03%4.01M

-6.91%4.08M

-6.79%4.16M

--4.23M

-6.57%4.31M

--4.38M

-6.60%4.46M

-6.37%4.61M

-5.91%4.78M

Fixed assets

----

32.13%107.72M

----

3.31%81.52M

----

-8.69%76.3M

--78.91M

43.20%83.56M

Constru in process

----

115.66%39.91M

----

681.89%18.51M

----

804.90%8.41M

--2.37M

-84.98%929.21K

Construction materials

----

--3.26M

----

Intangible assets

-0.13%19.49M

0.04%19.67M

0.85%19.78M

0.19%19.78M

--19.52M

-1.72%19.66M

--19.61M

-2.58%19.74M

-2.55%20M

11.68%20.26M

Long deferred expense

-50.74%385.14K

-90.88%101.97K

-84.73%197.96K

-85.69%257.54K

--781.9K

-54.48%1.12M

--1.3M

-45.02%1.8M

-40.00%2.46M

-34.48%3.27M

Deferred tax assets

----

--1.52M

-30.33%1.61M

--1.67M

30.71%1.79M

95.73%2.32M

57.22%1.37M

Usufruct assets

1,556.13%8.46M

1,434.12%8.41M

1,086.62%8.77M

-45.84%503.5K

--511.02K

-58.17%548.32K

--738.95K

-33.58%929.59K

-24.48%1.31M

-32.46%1.4M

Other non current assets

-69.36%1.57M

-33.57%3.8M

-54.05%3.43M

-35.13%3.88M

--5.14M

285.54%5.71M

--7.47M

508.53%5.98M

-6.25%1.48M

-65.03%983.48K

Total non current assets

42.54%200.35M

40.51%186.87M

35.69%170.65M

36.47%162.97M

--140.56M

17.22%132.99M

--125.76M

2.45%119.42M

9.48%113.46M

18.31%116.56M

Total assets

7.54%1.4B

7.94%1.38B

131.50%1.36B

137.08%1.34B

--1.3B

137.85%1.28B

--585.66M

18.50%565.6M

31.45%536.74M

30.61%477.31M

Liabilities

Current liabilities

Transactional financial liabilities

----

--2.63M

----

Notes payable and accounts payable

-15.76%31.42M

-15.40%37.2M

-45.27%25.79M

33.23%46.55M

--37.3M

-20.58%43.98M

--47.12M

-37.92%34.94M

22.99%55.37M

80.04%56.28M

-Notes payable

----

-70.58%5.77M

-12.42%13.93M

--14.07M

-38.78%19.24M

--19.61M

-59.07%15.91M

104.69%31.42M

275.78%38.86M

-Accounts payable

35.24%31.42M

50.37%37.2M

-27.22%20.02M

71.37%32.62M

--23.23M

3.30%24.74M

--27.51M

9.23%19.04M

-19.28%23.95M

-16.70%17.43M

Contract liabilities

52.33%9.46M

153.16%14.33M

-35.73%5.29M

-41.26%4.16M

--6.21M

-34.51%5.66M

--8.24M

-25.36%7.08M

47.49%8.64M

69.71%9.49M

Advance receipts

----

63.50%100K

----

Salaries payable

22.73%11.78M

23.61%10.33M

8.34%6.74M

5.66%13.19M

--9.6M

-11.95%8.35M

--6.22M

-0.77%12.49M

19.90%9.49M

23.09%12.58M

Taxs payable

8.83%8.74M

27.37%7.91M

-41.57%6.09M

-67.00%7.5M

--8.03M

-71.87%6.21M

--10.43M

67.90%22.73M

252.37%22.09M

-20.26%13.54M

Other payable (including interest and dividends)

12.06%5.94M

52.75%6.35M

65.69%4.85M

51.93%4.76M

--5.3M

73.57%4.15M

--2.92M

41.72%3.13M

-82.91%2.39M

-22.25%2.21M

-Other payable

----

52.75%6.35M

----

73.57%4.15M

----

41.72%3.13M

--2.39M

-22.25%2.21M

Non current liabilities due within one year

18.13%953.96K

39.80%1.14M

19.53%953.96K

-91.43%67.01K

--807.55K

6.53%814.35K

--798.11K

4.65%781.86K

4.65%764.46K

--747.12K

Other current liabilities

26.78%5.26M

32.66%5.15M

-8.08%2.31M

12.97%2.54M

--4.15M

7.37%3.88M

--2.51M

-71.95%2.25M

-39.86%3.62M

-19.34%8.01M

Total current liabilities

3.02%73.55M

12.80%82.42M

-33.50%52.03M

-5.55%78.77M

--71.4M

-30.49%73.06M

--78.25M

-18.92%83.4M

22.39%105.11M

33.67%102.86M

Current liabilities

Estimate liabilities

----

--243.26K

--521.04K

----

Deferred tax liabilities

14.84%8.87M

6.53%7.9M

5.01%6.9M

2.86%6.89M

--7.73M

14.28%7.41M

--6.58M

-1.25%6.7M

17.11%6.49M

60.67%6.78M

Long term deferred income

-3.45%5.66M

-1.78%5.66M

-5.97%5.85M

--5.87M

0.99%5.77M

--6.22M

11.40%6.22M

43.38%5.71M

81.62%5.59M

Lease liabilities

--8.39M

--7.83M

--7.93M

--99.89K

----

-57.57%663.82K

-65.14%781.93K

Total non current liabilities

68.63%22.92M

62.34%21.4M

58.58%20.68M

-2.46%12.84M

--13.59M

-1.51%13.18M

--13.04M

0.11%13.17M

20.71%13.38M

37.85%13.15M

Total liabilities

13.51%96.47M

20.37%103.81M

-20.34%72.72M

-5.13%91.62M

--84.99M

-27.22%86.24M

--91.29M

-16.76%96.57M

22.20%118.49M

34.13%116.02M

Shareholders equity

Paid-in capital

48.00%100.64M

33.33%68M

--68M

33.33%68M

--51M

0.00%51M

Capital reserve funds

-4.28%730.38M

631.55%763.02M

--763.02M

631.55%763.02M

--104.3M

0.00%104.3M

Surplus reserve funds

0.00%41.68M

--41.68M

34.96%41.68M

--41.68M

34.96%41.68M

43.81%30.88M

Retained profit

25.01%428.34M

26.19%399.43M

38.23%408.77M

38.66%375.39M

--342.65M

37.16%316.53M

--295.72M

55.59%270.72M

73.57%230.77M

72.56%174M

Specific reserves

109.60%1.93M

73.23%2.01M

-2.45%1.62M

-6.30%1.25M

--919.97K

-10.75%1.16M

--1.66M

19.91%1.33M

-20.05%1.3M

-18.06%1.11M

Shareholders equity without minority interests

7.13%1.3B

7.04%1.27B

159.54%1.28B

166.36%1.25B

--1.22B

184.61%1.19B

--494.36M

29.82%469.03M

34.33%418.25M

29.51%361.29M

Total shareholder equity

7.13%1.3B

7.04%1.27B

159.54%1.28B

166.36%1.25B

--1.22B

184.61%1.19B

--494.36M

29.82%469.03M

34.33%418.25M

29.51%361.29M

Total liabilityies and equity

7.54%1.4B

7.94%1.38B

131.50%1.36B

137.08%1.34B

--1.3B

137.85%1.28B

--585.66M

18.50%565.6M

31.45%536.74M

30.61%477.31M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021
Assets
Current assets
Money funds	-21.90%723.69M	-22.86%700.71M	293.68%951.78M	281.79%943.75M	--926.65M	306.07%908.36M	--241.76M	20.43%247.19M	41.69%223.7M	46.71%205.26M
Transactional financial assets	--250M	--250M	----	----	----	----	----	----	----	--740.3K
Notes receivable and accounts receivable	-5.47%41.18M	-16.48%49.58M	9.00%59.05M	24.72%54.32M	--43.56M	24.68%59.37M	--54.17M	91.10%43.55M	2.51%47.61M	-18.39%22.79M
-Notes receivable	--5.49M	--6.27M	--6.28M	--2.58M	----	----	----	----	----	----
-Accounts receivable	-18.07%35.69M	-27.04%43.31M	-2.59%52.77M	18.78%51.73M	--43.56M	24.68%59.37M	--54.17M	91.10%43.55M	2.51%47.61M	-18.39%22.79M
Other receivables (including interest and dividends)	65.97%253.75K	144.81%188.04K	-40.08%119.16K	69.76%72.37K	--152.89K	27.99%76.81K	--198.88K	49.10%42.63K	-71.38%60.01K	-90.39%28.59K
-Other receivable	----	144.81%188.04K	----	----	----	27.99%76.81K	----	49.10%42.63K	--60.01K	-90.39%28.59K
Advance payment	8.70%4.84M	14.17%3.01M	-61.34%2.42M	-15.05%2.25M	--4.45M	56.70%2.64M	--6.26M	148.42%2.65M	-7.80%1.68M	19.84%1.07M
Inventories	-10.55%141.42M	7.30%150.15M	-0.44%130.31M	11.68%159.31M	--158.1M	10.14%139.94M	--130.89M	35.93%142.65M	39.08%127.06M	21.77%104.94M
Receivable financing	80.34%21.98M	1.24%23.43M	51.40%30.48M	-8.90%3.41M	--12.19M	21.18%23.14M	--20.13M	-82.83%3.75M	218.66%19.1M	86.54%21.82M
Other current assets	0.87%15.74M	38.34%14.01M	69.79%11.01M	133.79%14.87M	--15.61M	148.18%10.13M	--6.48M	54.99%6.36M	316.51%4.08M	8,094.62%4.1M
Total current assets	3.31%1.2B	4.15%1.19B	157.70%1.19B	164.01%1.18B	--1.16B	170.18%1.14B	--459.89M	23.68%446.19M	38.92%423.29M	35.14%360.75M
Non Current assets
Investment real estate	-7.16%3.93M	-7.03%4.01M	-6.91%4.08M	-6.79%4.16M	--4.23M	-6.57%4.31M	--4.38M	-6.60%4.46M	-6.37%4.61M	-5.91%4.78M
Fixed assets	----	32.13%107.72M	----	----	----	3.31%81.52M	----	-8.69%76.3M	--78.91M	43.20%83.56M
Constru in process	----	115.66%39.91M	----	----	----	681.89%18.51M	----	804.90%8.41M	--2.37M	-84.98%929.21K
Construction materials	----	--3.26M	----	----	----	----	----	----	----	----
Intangible assets	-0.13%19.49M	0.04%19.67M	0.85%19.78M	0.19%19.78M	--19.52M	-1.72%19.66M	--19.61M	-2.58%19.74M	-2.55%20M	11.68%20.26M
Long deferred expense	-50.74%385.14K	-90.88%101.97K	-84.73%197.96K	-85.69%257.54K	--781.9K	-54.48%1.12M	--1.3M	-45.02%1.8M	-40.00%2.46M	-34.48%3.27M
Deferred tax assets	----	----	----	----	--1.52M	-30.33%1.61M	--1.67M	30.71%1.79M	95.73%2.32M	57.22%1.37M
Usufruct assets	1,556.13%8.46M	1,434.12%8.41M	1,086.62%8.77M	-45.84%503.5K	--511.02K	-58.17%548.32K	--738.95K	-33.58%929.59K	-24.48%1.31M	-32.46%1.4M
Other non current assets	-69.36%1.57M	-33.57%3.8M	-54.05%3.43M	-35.13%3.88M	--5.14M	285.54%5.71M	--7.47M	508.53%5.98M	-6.25%1.48M	-65.03%983.48K
Total non current assets	42.54%200.35M	40.51%186.87M	35.69%170.65M	36.47%162.97M	--140.56M	17.22%132.99M	--125.76M	2.45%119.42M	9.48%113.46M	18.31%116.56M
Total assets	7.54%1.4B	7.94%1.38B	131.50%1.36B	137.08%1.34B	--1.3B	137.85%1.28B	--585.66M	18.50%565.6M	31.45%536.74M	30.61%477.31M
Liabilities
Current liabilities
Transactional financial liabilities	----	----	----	----	----	----	----	----	--2.63M	----
Notes payable and accounts payable	-15.76%31.42M	-15.40%37.2M	-45.27%25.79M	33.23%46.55M	--37.3M	-20.58%43.98M	--47.12M	-37.92%34.94M	22.99%55.37M	80.04%56.28M
-Notes payable	----	----	-70.58%5.77M	-12.42%13.93M	--14.07M	-38.78%19.24M	--19.61M	-59.07%15.91M	104.69%31.42M	275.78%38.86M
-Accounts payable	35.24%31.42M	50.37%37.2M	-27.22%20.02M	71.37%32.62M	--23.23M	3.30%24.74M	--27.51M	9.23%19.04M	-19.28%23.95M	-16.70%17.43M
Contract liabilities	52.33%9.46M	153.16%14.33M	-35.73%5.29M	-41.26%4.16M	--6.21M	-34.51%5.66M	--8.24M	-25.36%7.08M	47.49%8.64M	69.71%9.49M
Advance receipts	----	----	----	----	----	----	----	----	63.50%100K	----
Salaries payable	22.73%11.78M	23.61%10.33M	8.34%6.74M	5.66%13.19M	--9.6M	-11.95%8.35M	--6.22M	-0.77%12.49M	19.90%9.49M	23.09%12.58M
Taxs payable	8.83%8.74M	27.37%7.91M	-41.57%6.09M	-67.00%7.5M	--8.03M	-71.87%6.21M	--10.43M	67.90%22.73M	252.37%22.09M	-20.26%13.54M
Other payable (including interest and dividends)	12.06%5.94M	52.75%6.35M	65.69%4.85M	51.93%4.76M	--5.3M	73.57%4.15M	--2.92M	41.72%3.13M	-82.91%2.39M	-22.25%2.21M
-Other payable	----	52.75%6.35M	----	----	----	73.57%4.15M	----	41.72%3.13M	--2.39M	-22.25%2.21M
Non current liabilities due within one year	18.13%953.96K	39.80%1.14M	19.53%953.96K	-91.43%67.01K	--807.55K	6.53%814.35K	--798.11K	4.65%781.86K	4.65%764.46K	--747.12K
Other current liabilities	26.78%5.26M	32.66%5.15M	-8.08%2.31M	12.97%2.54M	--4.15M	7.37%3.88M	--2.51M	-71.95%2.25M	-39.86%3.62M	-19.34%8.01M
Total current liabilities	3.02%73.55M	12.80%82.42M	-33.50%52.03M	-5.55%78.77M	--71.4M	-30.49%73.06M	--78.25M	-18.92%83.4M	22.39%105.11M	33.67%102.86M
Current liabilities
Estimate liabilities	----	----	----	----	----	----	--243.26K	--243.26K	--521.04K	----
Deferred tax liabilities	14.84%8.87M	6.53%7.9M	5.01%6.9M	2.86%6.89M	--7.73M	14.28%7.41M	--6.58M	-1.25%6.7M	17.11%6.49M	60.67%6.78M
Long term deferred income	-3.45%5.66M	-1.78%5.66M	-5.97%5.85M	-5.97%5.85M	--5.87M	0.99%5.77M	--6.22M	11.40%6.22M	43.38%5.71M	81.62%5.59M
Lease liabilities	--8.39M	--7.83M	--7.93M	--99.89K	----	----	----	----	-57.57%663.82K	-65.14%781.93K
Total non current liabilities	68.63%22.92M	62.34%21.4M	58.58%20.68M	-2.46%12.84M	--13.59M	-1.51%13.18M	--13.04M	0.11%13.17M	20.71%13.38M	37.85%13.15M
Total liabilities	13.51%96.47M	20.37%103.81M	-20.34%72.72M	-5.13%91.62M	--84.99M	-27.22%86.24M	--91.29M	-16.76%96.57M	22.20%118.49M	34.13%116.02M
Shareholders equity
Paid-in capital	48.00%100.64M	48.00%100.64M	33.33%68M	33.33%68M	--68M	33.33%68M	--51M	0.00%51M	0.00%51M	0.00%51M
Capital reserve funds	-4.28%730.38M	-4.28%730.38M	631.55%763.02M	631.55%763.02M	--763.02M	631.55%763.02M	--104.3M	0.00%104.3M	0.00%104.3M	0.00%104.3M
Surplus reserve funds	0.00%41.68M	0.00%41.68M	0.00%41.68M	0.00%41.68M	--41.68M	34.96%41.68M	--41.68M	34.96%41.68M	43.81%30.88M	43.81%30.88M
Retained profit	25.01%428.34M	26.19%399.43M	38.23%408.77M	38.66%375.39M	--342.65M	37.16%316.53M	--295.72M	55.59%270.72M	73.57%230.77M	72.56%174M
Specific reserves	109.60%1.93M	73.23%2.01M	-2.45%1.62M	-6.30%1.25M	--919.97K	-10.75%1.16M	--1.66M	19.91%1.33M	-20.05%1.3M	-18.06%1.11M
Shareholders equity without minority interests	7.13%1.3B	7.04%1.27B	159.54%1.28B	166.36%1.25B	--1.22B	184.61%1.19B	--494.36M	29.82%469.03M	34.33%418.25M	29.51%361.29M
Total shareholder equity	7.13%1.3B	7.04%1.27B	159.54%1.28B	166.36%1.25B	--1.22B	184.61%1.19B	--494.36M	29.82%469.03M	34.33%418.25M	29.51%361.29M
Total liabilityies and equity	7.54%1.4B	7.94%1.38B	131.50%1.36B	137.08%1.34B	--1.3B	137.85%1.28B	--585.66M	18.50%565.6M	31.45%536.74M	30.61%477.31M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	Unqualified opinion
Auditor	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

001367 Zhejiang Haisen Pharmaceutical

Zhejiang Haisen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target